Literature DB >> 21115936

Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.

Bahir Aldulaymi1, Ib J Christensen, György Sölétormos, Per Jess, Svend Erik Nielsen, Søren Laurberg, Nils Brünner, Hans J Nielsen.   

Abstract

BACKGROUND: Preoperative biomarkers serum CEA and plasma TIMP-1 have been shown to have prognostic and predictive value in patients with colorectal cancer. The aim of the present study was to evaluate the possible impact of chemoradiotherapy (CRT) on preoperative biomarker levels in patients with rectal cancer. PATIENTS AND METHODS: Thirty-three patients with rectal cancer were prospectively included. The patients received CRT for 6-8 weeks. Blood samples were collected before CRT (pre-CRT) and preoperatively (post-CRT).
RESULTS: Median CEA was 3.5 (range 0.6-36.1) μg/l and 2.4 (range 0.0-10.2) μg/l (p=0.002) and median plasma TIMP-1 was 132.1 (range 77.8-342.7) μg/l and 140.0 (range 82.6-440.9) μg/l (p=0.04) in the pre- and post-CRT measurements, respectively.
CONCLUSION: CRT induced a significant decrease in serum CEA and increase in plasma TIMP-1 levels. Therefore, the preoperative biomarker levels may be affected by treatments received before blood sample collection. Translation of results of preoperative biomarkers needs to take such facts into consideration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115936

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.

Authors:  Alexander Gaber; Christina Stene; Kristina Hotakainen; Björn Nodin; Ingrid Palmquist; Anders Bjartell; Ulf-Håkan Stenman; Bengt Jeppsson; Louis B Johnson; Karin Jirström
Journal:  Radiat Oncol       Date:  2011-08-24       Impact factor: 3.481

2.  A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface.

Authors:  Xiaoxiao Li; James LeBlanc; Allison Truong; Ravi Vuthoori; Sharon S Chen; Jonathan L Lustgarten; Bennett Roth; Jeff Allard; Andrew Ippoliti; Laura L Presley; James Borneman; William L Bigbee; Vanathi Gopalakrishnan; Thomas G Graeber; David Elashoff; Jonathan Braun; Lee Goodglick
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

3.  Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.

Authors:  Peter Jo; Azadeh Azizian; Junius Salendo; Frank Kramer; Markus Bernhardt; Hendrik A Wolff; Jens Gruber; Marian Grade; Tim Beißbarth; B Michael Ghadimi; Jochen Gaedcke
Journal:  Int J Mol Sci       Date:  2017-05-27       Impact factor: 5.923

Review 4.  Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.

Authors:  Delphine Dayde; Ichidai Tanaka; Rekha Jain; Mei Chee Tai; Ayumu Taguchi
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.